trastuzumab,tucatinib
Seagen,Roche
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'tucatinib']
 less risk of ild so i would do tucatinib and trastuzumab if given an option
GI Medical Oncologist| #FoxChaseCancerCenter l Focus NETs and CRC | Lifelong learner and nature lover